Evidence map›Paper›PMID 32634220›Full record

Trial reportSchizophrenia bulletin2021

The Psychopathology and Neuroanatomical Markers of Depression in Early Psychosis.

Rachel Upthegrove, Paris Lalousis, Pavan Mallikarjun, Katharine Chisholm, Sian Lowri Griffiths, Mariam Iqbal, Mirabel Pelton, Renate Reniers, Alexandra Stainton, Marlene Rosen and 19 more

Abstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Schizophrenia bulletin, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Rachel UpthegroveInstitute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.
Paris LalousisInstitute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.
Pavan MallikarjunInstitute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.
Katharine ChisholmInstitute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.
Sian Lowri GriffithsInstitute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.
Mariam IqbalInstitute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.
Mirabel PeltonInstitute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.
Renate ReniersInstitute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.
Alexandra StaintonOrygen, The National Centre of Excellence in Youth Mental Health, Melbourne, Australia.
Marlene RosenDepartment of Psychiatry and Psychotherapy, Ludwig Maximilian University, Munich, Germany.
Anne RuefDepartment of Psychiatry and Psychotherapy, Ludwig Maximilian University, Munich, Germany.
Dominic B DwyerDepartment of Psychiatry and Psychotherapy, Ludwig Maximilian University, Munich, Germany.
Marian SurmanDepartment of Mental Health, University of Münster, Münster, Germany.
Theresa HaidlDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
Nora PenzelDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
Lana Kambeitz-LlankovicDepartment of Psychiatry and Psychotherapy, Ludwig Maximilian University, Munich, Germany.
Alessandro BertolinoDepartment of Basic Medical Science, Neuroscience and Sense Organs, University of Bari "Aldo Moro," Bari, Italy.
Paolo BrambillaDepartment of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Stefan BorgwardtDepartment of Psychiatry (Psychiatric University Hospital, UPK), University of Basel, Basel, Switzerland.
Joseph KambeitzDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
Rebekka LencerDepartment of Mental Health, University of Münster, Münster, Germany.
Christos PantelisMelbourne Neuropsychiatry Centre, University of Melbourne and Melbourne Health, Melbourne, Australia.
Stephan RuhrmannDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
Frauke Schultze-LutterDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
Raimo K R SalokangasDepartment of Psychiatry, University of Turku, Turku, Finland.
Eva MeisenzahlDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
Stephen J WoodInstitute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.
Nikolaos KoutsoulerisDepartment of Psychiatry and Psychotherapy, Ludwig Maximilian University, Munich, Germany.
PRONIA Consortium

Funding

Medical Research Council MR/S037675/1
6 · The paper itself

Abstract

Depression frequently occurs in first-episode psychosis (FEP) and predicts longer-term negative outcomes. It is possible that this depression is seen primarily in a distinct subgroup, which if identified could allow targeted treatments. We hypothesize that patients with recent-onset psychosis (ROP) and comorbid depression would be identifiable by symptoms and neuroanatomical features similar to those seen in recent-onset depression (ROD). Data were extracted from the multisite PRONIA study: 154 ROP patients (FEP within 3 months of treatment onset), of whom 83 were depressed (ROP+D) and 71 who were not depressed (ROP-D), 146 ROD patients, and 265 healthy controls (HC). Analyses included a (1) principal component analysis that established the similar symptom structure of depression in ROD and ROP+D, (2) supervised machine learning (ML) classification with repeated nested cross-validation based on depressive symptoms separating ROD vs ROP+D, which achieved a balanced accuracy (BAC) of 51%, and (3) neuroanatomical ML-based classification, using regions of interest generated from ROD subjects, which identified BAC of 50% (no better than chance) for separation of ROP+D vs ROP-D. We conclude that depression at a symptom level is broadly similar with or without psychosis status in recent-onset disorders; however, this is not driven by a separable depressed subgroup in FEP. Depression may be intrinsic to early stages of psychotic disorder, and thus treating depression could produce widespread benefit.

Indexed as

AdolescentAdultDepressionFemaleGray MatterHumansMagnetic Resonance ImagingMalePrincipal Component AnalysisPsychotic DisordersSchizophreniaSupervised Machine LearningYoung Adultdepressiongray matter volumemachine learningpsychopathologypsychosisschizophrenia

Identifiers

PMID32634220
PMCPMC7825071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.